Combination diphenylcyclopropenone, anthralin effectively treats alopecia areata
Combination therapy of diphenylcyclopropenone and anthralin was superior to diphenylcyclopropenone monotherapy as treatment for chronic alopecia areata, according to recently published study results.
Researchers in Turkey conducted a retrospective analysis of diphenylcyclopropenone (DPCP)’s efficacy, side effects and relapse rates, as monotherapy or with anthralin, in the treatment of 47 patients with severe (>50% scalp hair loss) and/or treatment-resistant alopecia areata (AA) who had been followed-up for the prior 4 years.